Treatment of all these leukaemia cells with the inflammatory mediator lipopolysaccharide (LPS) further upregulates LPHN1 translation via mammalian target of rapamycin (mTOR, a master regulator of myeloid cell translation and growth [14]). This evidence concerns the gene MTOR and leukemia.